← Back to catalogue

BD ProbeTec™ Chlamydia trachomatis (CT) Qx Amplified DNA Assay

FDA UDI

Class II (US FDA UDI)

by Becton Dickinson And Company

Identity

Trade Name
BD ProbeTec™ Chlamydia trachomatis (CT) Qx Amplified DNA Assay FDA UDI
Generic Name
Chlamydia trachomatis nucleic acid IVD, kit, nucleic acid technique (NAT) FDA UDI
Device Name
Kit CT Qx Amplified Dna Assay FDA UDI
Model / Reference
441126 FDA UDI
Description
Kit CT Qx Amplified Dna Assay FDA UDI

Identifiers

Catalog Number
441126 FDA UDI
Primary DI / UDI-DI
00382904411268 FDA UDI
510(k) Number
K081824 FDA UDI
K090824 FDA UDI
K091724 FDA UDI
FDA Product Code
LSL FDA UDI
MKZ FDA UDI
GMDN Term
Chlamydia trachomatis nucleic acid IVD, kit, nucleic acid technique (NAT) FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
866.3390 FDA UDI
866.3120 FDA UDI
Commercial Distribution
Not in Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

BD ProbeTec™ Chlamydia trachomatis (CT) Qx Amplified DNA Assay by Becton Dickinson And Company — Class II — FDA UDI — listed in FDA GUDID

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI ab086da1-2fa1-4122-a70c-86164969ab94 38 fields · synced May 29, 2026